ADMA Biologics, Inc. (ADMA)
9.33
-0.06
(-0.64%)
USD |
NASDAQ |
Sep 01, 16:00
9.34
+0.01
(+0.11%)
After-Hours: 20:00
ADMA Biologics Net Income (TTM) : 168.96M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 168.96M |
| March 31, 2026 | 165.35M |
| December 31, 2025 | 146.93M |
| September 30, 2025 | 209.45M |
| June 30, 2025 | 208.93M |
| March 31, 2025 | 206.77M |
| December 31, 2024 | 197.67M |
| September 30, 2024 | 68.13M |
| June 30, 2024 | 34.79M |
| March 31, 2024 | -3.644M |
| December 31, 2023 | -28.24M |
| September 30, 2023 | -22.83M |
| June 30, 2023 | -40.29M |
| March 31, 2023 | -47.68M |
| December 31, 2022 | -65.90M |
| September 30, 2022 | -70.32M |
| June 30, 2022 | -73.14M |
| March 31, 2022 | -78.28M |
| December 31, 2021 | -71.65M |
| September 30, 2021 | -74.41M |
| June 30, 2021 | -73.61M |
| March 31, 2021 | -74.88M |
| December 31, 2020 | -75.75M |
| September 30, 2020 | -66.90M |
| June 30, 2020 | -61.42M |
| Date | Value |
|---|---|
| March 31, 2020 | -54.46M |
| December 31, 2019 | -48.28M |
| September 30, 2019 | -55.76M |
| June 30, 2019 | -59.45M |
| March 31, 2019 | -60.99M |
| December 31, 2018 | -65.74M |
| September 30, 2018 | -60.69M |
| June 30, 2018 | -60.76M |
| March 31, 2018 | -55.04M |
| December 31, 2017 | -43.76M |
| September 30, 2017 | -35.34M |
| June 30, 2017 | -24.46M |
| March 31, 2017 | -21.44M |
| December 31, 2016 | -19.52M |
| September 30, 2016 | -19.54M |
| June 30, 2016 | -20.31M |
| March 31, 2016 | -18.98M |
| December 31, 2015 | -17.97M |
| September 30, 2015 | -16.95M |
| June 30, 2015 | -15.23M |
| March 31, 2015 | -14.51M |
| December 31, 2014 | -16.81M |
| September 30, 2014 | -17.95M |
| June 30, 2014 | -17.26M |
| March 31, 2014 | -18.19M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Erasca, Inc. | -287.22M |
| Krystal Biotech, Inc. | 241.46M |
| Vericel Corp. | 24.22M |
| Emergent BioSolutions, Inc. | -176.80M |
| Exelixis, Inc. | 860.62M |